Cetirizine Dihydrochloride
The active substance of Letizen is cetirizine dihydrochloride.
Letizen is an antiallergic medication.
Letizen, 10 mg, film-coated tablets are indicated for adults and children aged 6 years and above:
Before taking Letizen, discuss it with your doctor or pharmacist.
If you have renal impairment, consult your doctor before taking the medicine;
a lower dose may be necessary. The dose will be determined by your doctor.
If you have a history of epilepsy or are at risk of seizures, consult your doctor.
If you have difficulty urinating (e.g., spinal cord injury, prostate problems, or bladder problems), consult your doctor.
If you are scheduled to undergo allergy testing, ask your doctor whether you should stop taking Letizen a few days before the test. This medicine may affect the results of allergy tests.
No significant clinically relevant interactions have been observed between alcohol (at a concentration of 0.5 g/L in the blood, corresponding to the concentration after drinking one glass of wine) and cetirizine at the recommended dose. However, there are no data on the safety of concomitant use of higher doses of cetirizine and alcohol. Therefore, as with other antihistamine medications, it is recommended to avoid taking Letizen with alcohol.
Do not give this medicine to children under 6 years of age, as the tablet formulation does not allow for appropriate dose adjustment.
Tell your doctor or pharmacist about all medicines you are taking, have recently taken, or might take.
Food does not affect the absorption of Letizen.
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor for advice before taking this medicine.
Avoid taking Letizen during pregnancy. Accidental intake of the medicine by a pregnant woman should not have a harmful effect on the fetus. However, the medicine should only be used if necessary and after consulting a doctor.
Cetirizine passes into breast milk. In breastfed infants, it cannot be excluded that adverse effects may occur. Therefore, do not take Letizen during breastfeeding, unless your doctor decides otherwise.
Clinical studies with cetirizine at the recommended dose have not shown any significant impairment of reaction time or alertness, or any effect on the ability to drive or operate machinery.
If you plan to drive a vehicle, perform potentially hazardous activities, or operate machinery after taking Letizen, carefully observe your body's reaction to the medicine. Do not exceed the recommended dose.
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.
Always take this medicine exactly as your doctor or pharmacist has told you. If you are not sure, ask your doctor or pharmacist.
Swallow the tablets with a glass of liquid.
The recommended dose is 10 mg (1 tablet) once daily.
The recommended dose is 5 mg twice daily (half a tablet twice daily).
Other formulations of cetirizine may be more suitable for children. Consult your doctor or pharmacist.
In patients with moderate renal impairment, a dose of 5 mg once daily is recommended.
If you have severe kidney disease, consult your doctor, who will adjust the dose accordingly.
If your child has kidney disease, consult your doctor, who will adjust the dose according to your child's needs.
If you feel that the effect of Letizen is too strong or too weak, consult your doctor.
The duration of treatment depends on the type, duration, and course of the disease and is determined by your doctor.
If you take more Letizen than you should, contact your doctor immediately.
Your doctor will decide what measures should be taken.
After taking a higher dose than recommended, the following side effects may occur with increased intensity: disorientation, diarrhea, dizziness, fatigue, headache, malaise, dilated pupils, itching, restlessness, especially motor, sedation, somnolence, stupor, accelerated heart rate, tremor, urinary retention (difficulty emptying the bladder completely).
Do not take a double dose to make up for a forgotten dose.
In rare cases, itching (intense itching) and/or urticaria may recur after stopping Letizen treatment.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, Letizen can cause side effects, although not everybody gets them.
Common Side Effects(may affect up to 1 in 10 people):
Uncommon Side Effects(may affect up to 1 in 100 people):
Rare Side Effects(may affect up to 1 in 1,000 people):
Very Rare Side Effects(may affect up to 1 in 10,000 people):
Side Effects with Unknown Frequency(frequency cannot be estimated from the available data):
If you experience any side effects, including any not listed in this leaflet, please inform your doctor or pharmacist. Side effects can be reported directly to the Department of Medicinal Product Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products:
Al. Jerozolimskie 181C
02-222 Warsaw
tel.: +48 22 49 21 301
fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Store in a temperature below 30°C.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Round, slightly biconvex, white film-coated tablets with a notch on one side.
The tablet can be divided into equal doses.
Pack sizes: 7 or 20 film-coated tablets in blisters in a cardboard box.
KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia
To obtain more detailed information on this medicine, contact the local representative of the marketing authorization holder:
KRKA-POLSKA Sp. z o.o.
ul. Równoległa 5
02-235 Warsaw
tel. 22 57 37 500
Date of Last Revision of the Leaflet:
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.